Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmatrix (PULM) Capital Expenditures (2016 - 2024)

Pulmatrix (PULM) has disclosed Capital Expenditures for 11 consecutive years, with $244000.0 as the latest value for Q2 2024.

  • Quarterly Capital Expenditures changed N/A to $244000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $398000.0 through Dec 2024, up 14.37% year-over-year, with the annual reading at $398000.0 for FY2024, 2.31% up from the prior year.
  • Capital Expenditures hit $244000.0 in Q2 2024 for Pulmatrix, up from $154000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $614000.0 in Q3 2023 to a low of -$275000.0 in Q4 2023.
  • Historically, Capital Expenditures has averaged $94615.4 across 5 years, with a median of $83000.0 in 2020.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 860.0% in 2020 and later plummeted 3155.56% in 2023.
  • Year by year, Capital Expenditures stood at $83000.0 in 2020, then plummeted by 68.67% to $26000.0 in 2021, then plummeted by 65.38% to $9000.0 in 2022, then tumbled by 3155.56% to -$275000.0 in 2023, then skyrocketed by 188.73% to $244000.0 in 2024.
  • Business Quant data shows Capital Expenditures for PULM at $244000.0 in Q2 2024, $154000.0 in Q1 2024, and -$275000.0 in Q4 2023.